Step into the light of innovation by watching the recording of the BeOne-sponsored Satellite Symposium, where a faculty of experts unlocked new perspectives in lymphoma care.

The recording of the Satellite Symposium will provide an opportunity to increase your understanding of:

• The latest advancements in Bruton’s tyrosine kinase inhibitor (BTKi)-based therapeutic options for chronic lymphocytic leukemia (CLL)
• Current and emerging treatment strategies for Waldenström’s macroglobulinemia (WM), from BTKi monotherapies to promising combinations
• The evolving role and future potential of BTKis in mantle cell lymphoma (MCL) and marginal zone lymphoma (MZL)
• BTK protein degraders as a promising new approach to the treatment of lymphomas

Watch the recording and learn about the future of lymphoma treatment from leading experts sharing their firsthand experience with therapeutic options targeting BTK. You will also find the slides available for download.